Pepe Vera Lúcia Edais, Figueiredo Tatiana de Aragão, Simas Luciana, Osorio-de-Castro Claudia Garcia Serpa, Ventura Míriam
Centro Colaborador em Vigilância Sanitária, Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sérgio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, 21041210.
Cien Saude Colet. 2010 Aug;15(5):2405-14. doi: 10.1590/s1413-81232010000500015.
Health litigation spurs many challenges in the management of pharmaceutical services. Performance of health managers and decisionmakers must be adjusted to new administrative and legal boundaries. Their actions must also be efficient in responding to ongoing lawsuits, as well as in avoiding additional litigation and in upholding principles and directives of the Brazilian Health System (SUS). This paper proposes to better understand one of the aspects of health litigation, namely the growing use of lawsuits demanding medicines, and the relationship between this phenomenon and pharmaceutical services management in SUS. Through review and analysis of available published research on the subject, from various Brazilian states, the main elements of "medicines litigation" are presented and examined in light of their interference on the activities of the pharmaceutical services cycle. The analysis points to possible mechanisms to be adopted by decision-makers in management and in the Judicial System, since the right to health can only be effectively established when management and Justice are predominantly aware and committed to the safety and the protection of patients and users.
医疗诉讼给药品服务管理带来了诸多挑战。卫生管理人员和决策者的工作表现必须适应新的行政和法律界限。他们的行动还必须高效地应对正在进行的诉讼，避免引发更多诉讼，并坚持巴西卫生系统（SUS）的原则和指令。本文旨在更好地理解医疗诉讼的一个方面，即要求提供药品的诉讼日益增多的情况，以及这一现象与SUS药品服务管理之间的关系。通过回顾和分析巴西不同州关于该主题的已发表研究，阐述了“药品诉讼”的主要要素，并根据其对药品服务周期活动的干扰进行了审视。分析指出了管理人员和司法系统的决策者可能采用的机制，因为只有当管理部门和司法部门充分意识到并致力于保障患者和使用者的安全与权益时，健康权才能得到有效落实。
